These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34347700)

  • 41. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
    Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
    J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling in Ki-67 labeling index and grading of brain gliomas].
    Wang CC; Dong HB; Ding F; Li YD; Wang GY; Ding HX
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):338-342. PubMed ID: 30772973
    [No Abstract]   [Full Text] [Related]  

  • 43. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Fouke SJ; Benzinger T; Gibson D; Ryken TC; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):457-79. PubMed ID: 26530262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping.
    Lewis MA; Ganeshan B; Barnes A; Bisdas S; Jaunmuktane Z; Brandner S; Endozo R; Groves A; Thust SC
    Eur J Radiol; 2019 Apr; 113():116-123. PubMed ID: 30927935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Data-driven grading of brain gliomas: a multiparametric MR imaging study.
    Caulo M; Panara V; Tortora D; Mattei PA; Briganti C; Pravatà E; Salice S; Cotroneo AR; Tartaro A
    Radiology; 2014 Aug; 272(2):494-503. PubMed ID: 24661247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensities.
    Schäfer ML; Maurer MH; Synowitz M; Wüstefeld J; Marnitz T; Streitparth F; Wiener E
    Eur Radiol; 2013 Oct; 23(10):2846-53. PubMed ID: 23686293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
    PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic Value of Magnetic Resonance Spectroscopy Compared with Stereotactic Biopsy of Intra-axial Brain Lesions.
    Abdelaziz O; Eshra M; Belal A; Elshafei M
    J Neurol Surg A Cent Eur Neurosurg; 2016 Jul; 77(4):283-90. PubMed ID: 26935295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using R2* values to evaluate brain tumours on magnetic resonance imaging: preliminary results.
    Liu Z; Liao H; Yin J; Li Y
    Eur Radiol; 2014 Mar; 24(3):693-702. PubMed ID: 24275803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
    Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
    Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
    Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C
    J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis.
    Nakamoto T; Takahashi W; Haga A; Takahashi S; Kiryu S; Nawa K; Ohta T; Ozaki S; Nozawa Y; Tanaka S; Mukasa A; Nakagawa K
    Sci Rep; 2019 Dec; 9(1):19411. PubMed ID: 31857632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques.
    Kern M; Auer TA; Fehrenbach U; Tanyildizi Y; Picht T; Misch M; Wiener E
    Neuroradiol J; 2020 Apr; 33(2):160-168. PubMed ID: 31957551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The utility of magnetic resonance spectroscopy in frame-less stereotactic needle biopsy of glioma.
    Wang Q; Zhang J; Li F; Chen X; Xu B
    J Clin Neurosci; 2021 Jun; 88():102-107. PubMed ID: 33992167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.